UPDATE : Monday, March 30, 2020
상단여백
Daewoong’s Jeuveau sold ₩40 billion in US in 8 months by Jeong Sae-im 2020-01-21 11:43
CoImmune acquires Formula Pharmaceuticals by Lee Han-soo 2020-01-20 15:45
Pfizer’s spinoff of generics unit causes disputes with trade union by Kim Yun-mi 2020-01-20 15:44
Korea’s botulinum toxin exports hit record high in 2019 by Jeong Sae-im 2020-01-20 11:38
Takeda’s Kynteles expands indication for ulcerative colitis, Crohn’s disease by Kim Yun-mi 2020-01-17 17:30
라인
GenScript to market Genopis' GMP-grade plasmid DNA by Lee Han-soo 2020-01-17 17:28
AbbVie says its psoriasis drug superior to Novartis’ treatment by Lee Han-soo 2020-01-17 17:28
HanAll, Daewoong unveil P3 topline results for dry eye treatment by Lee Han-soo 2020-01-16 15:46
Genome to conduct immunotherapy combo trial with Merck, Pfizer by Lee Han-soo 2020-01-16 14:47
GSK to target ovarian cancer, multiple myeloma, endometrial cancer by Kim Yun-mi 2020-01-16 14:10
라인
Sweden prolongs financial support for IVI’s vaccine development by Lee Han-soo 2020-01-16 10:45
Pharmaceutical association lays out plans for 2020 by Lee Han-soo 2020-01-15 14:29
AptaBio attending J.P. Morgan event for global collaboration by Shim Hyun-tai 2020-01-15 13:06
GC Pharma's US offshoot opens new plasma center by Shim Hyun-tai 2020-01-15 13:05
Jeil, Oncocross to discover new indications for stroke therapy by Lee Han-soo 2020-01-15 11:31
라인
Will Steglatro prove SGLT-2 inhibitor’s cardiovascular benefits? by Kim Yun-mi 2020-01-14 15:28
Genexine becomes largest shareholder of GenNBio by Lee Han-soo 2020-01-14 11:11
Daewoong, A2A to develop AI-based anticancer treatment by Lee Han-soo 2020-01-14 10:35
GSK shows meaningful response rate for treatment of multiple myeloma by Lee Han-soo 2020-01-13 17:48
Zejula widens indication as monotherapy for ovarian cancer by Kim Yun-mi 2020-01-13 16:25
여백
여백
여백
여백
Back to Top